PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors

Journal of Neuroscience

Volumn 33, Issue 14, 2013, Pages 6203-6211

  Melis, Miriam ^a,b   Scheggi, Simona ^c   Carta, Gianfranca ^a   Madeddu, Camilla ^a   Lecca, Salvatore ^a   Luchicchi, Antonio ^a   Cadeddu, Francesca ^a   Frau, Roberto ^a   Fattore, Liana ^b   Fadda, Paola ^a   Grazia Ennas, M ^a   Paola Castelli, M ^a   Fratta, Walter ^a   Schilstrom, Bjorn ^d   Banni, Sebastiano ^a   Graziella de Montis, M ^c   Pistis, Marco ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CHEMOLUMINESCENCE; CHOLINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; FORCED SWIMMING TEST; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MENTAL DISEASE; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BENZAMIDES; BICYCLO COMPOUNDS; CARBAMATES; CHOLINERGIC AGENTS; DIHYDRO-BETA-ERYTHROIDINE; DOPAMINERGIC NEURONS; DRUG INTERACTIONS; ENZYME INHIBITORS; ETHANOLAMINES; EXCITATORY AMINO ACID ANTAGONISTS; LIGANDS; MALE; PATCH-CLAMP TECHNIQUES; PPAR ALPHA; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SWIMMING; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 84875996700     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4647-12.2013     Document Type: Article

References (79)

1. Acker BA, Jacobsen EJ, Rogers BN, Wishka DG, Reitz SC, PiotrowskiDW, Myers JK, Wolfe ML, Groppi VE, Thornburgh BA, Tinholt PM, Walters RR, Olson BA, Fitzgerald L, Staton BA, Raub TJ, Krause M, Li KS, Hoffmann WE, Hajos M, et al. (2008) Discovery of N+-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activity. Bioorg Med Chem Lett 18:3611-3615. CrossRef Medline
2. Adamczyk P, Golda A, McCreary AC, Filip M, Przegalinski E (2008) Activation of endocannabinoid transmission induces antidepressant-like effects in rats. J Physiol Pharmacol 59:217-228. Medline
3. Albanese A, MinciacchiD (1983) Organization of the ascending projections from the ventral tegmental area: a multiple fluorescent retrograde tracer study in the rat. J Comp Neurol 216:406-420. CrossRef Medline
4. Andreasen JT, Redrobe JP (2009) Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex. Behav Pharmacol 20:286-295. CrossRef Medline
5. Astarita G, Ahmed F, Piomelli D (2008) Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain. J Lipid Res 49:48-57. CrossRef Medline
6. Avena NM, Rada PV (2012) Cholinergic modulation of food and drug satiety and withdrawal. Physiol Behav 106:332-336. CrossRef Medline
7. Bencherif M, Lippiello PM, Lucas R, Marrero MB (2011) Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci 68:931-949. CrossRef Medline
8. Bertrand D, Galzi JL, Devillers-Thiéry A, Bertrand S, Changeux JP (1993) Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotinic receptor. Proc Natl Acad Sci U S A 90:6971-6975. CrossRef Medline
9. Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2007) Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiatry 62:1103-1110. CrossRef Medline
10. Caldarone BJ, Harrist A, Cleary MA, Beech RD, King SL, Picciotto MR (2004) High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation. Biol Psychiatry 56:657-664. CrossRef Medline
11. Castagne V, Moser P, Roux S, Porsolt RD (2011) Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci Chapter 8:Unit 8.10A. CrossRef Medline
12. Clarke PB, Schwartz RD, Paul SM, Pert CB, Pert A (1985) Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin. J Neurosci 5:1307-1315. Medline
13. Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB, Shrikhande A, Heym JH, Schaeffer E, Rollema H, Lu Y, Mansbach RS, Chambers LK, Rovetti CC, Schulz DW, Tingley FD 3rd, et al. (2005) Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 48:3474-3477. CrossRef Medline
14. Costa M, Squassina A, Congiu D, Chillotti C, Niola P, Galderisi S, Pistis M, Del Zompo M (2013) Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptoralpha gene (PPARA) and schizophrenia. Eur Neuropsychopharmacol, in press. Medline
15. Cullingford TE, Bhakoo K, Peuchen S, Dolphin CT, Patel R, Clark JB (1998) Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J Neurochem 70:1366-1375. CrossRef Medline
16. Di Marzo V, Melck D, Orlando P, Bisogno T, Zagoory O, Bifulco M, Vogel Z, De Petrocellis L (2001) Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem J 358:249-255. CrossRef Medline
17. Freedman R, Adams CE, Leonard S (2000) The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. J Chem Neuroanat 20:299-306. CrossRef Medline
18. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodríguez De Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, Piomelli D (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425:90-93. CrossRef Medline
19. Galan-Rodriguez B, Suarez J, Gonzalez-Aparicio R, Bermudez-Silva FJ, Maldonado R, Robledo P, Rodriguez de Fonseca F, Fernandez-Espejo E (2009) Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons. Neuropharmacology 56:653-664. CrossRef Medline
20. Gentry CL, Lukas RJ (2002) Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr Drug Targets CNS Neurol Disord 1:359-385. CrossRef Medline
21. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D (2005) Antidepressantlike activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102:18620-18625. CrossRef Medline
22. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, Freund TF (2004) Segregation of two endocannabinoid-hydrolyzing enzymes into pre-and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 20:441-458. CrossRef Medline
23. Janowsky DS, el-Yousef MK, Davis JM, Sekerke HJ (1972) A cholinergicadrenergic hypothesis of mania and depression. Lancet 2:632-635. Medline
24. Jones IW, Wonnacott S (2004) Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area. J Neurosci 24:11244-11252. CrossRef Medline
25. Kainu T, Wikström AC, Gustafsson JA, Pelto-Huikko M (1994) Localization of the peroxisome proliferator-activated receptor in the brain. Neuroreport 5:2481-2485. CrossRef Medline
26. Klink R, de Kerchove d'Exaerde A, Zoli M, Changeux JP (2001) Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21:1452-1463. Medline
27. Koch M, Kreutz S, Böttger C, Benz A, Maronde E, Ghadban C, Korf HW, Dehghani F (2011) Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-alpha. Neurotox Res 19:330-340. CrossRef Medline
28. Kucinski A, Syposs C, Wersinger S, Bencherif M, Stachowiak MK, Stachowiak EK (2012) alpha7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia. Schizophr Res 136:82-87. CrossRef Medline
29. Lakhan SE, Kirchgessner A (2011) Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. J Transl Med 9:129. CrossRef Medline
30. Lapish CC, Kroener S, Durstewitz D, Lavin A, Seamans JK (2007) The ability of the mesocortical dopamine system to operate in distinct temporal modes. Psychopharmacology (Berl) 191:609-625. CrossRef Medline
31. Lecca S, Melis M, Luchicchi A, Muntoni AL, Pistis M (2012) Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology 37:1164-1176. CrossRef Medline
32. Lodge DJ, Grace AA (2006) The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons. Proc Natl Acad Sci U S A 103:5167-5172. CrossRef Medline
33. LoVerme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D (2005) The nuclear receptor peroxisome proliferator-activated receptoralpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 67:15-19. CrossRef Medline
34. Mameli-Engvall M, Evrard A, Pons S, Maskos U, Svensson TH, Changeux JP, Faure P (2006) Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50:911-921. CrossRef Medline
35. Mao D, Gallagher K, McGehee DS (2011) Nicotine potentiation of excitatory inputs to ventral tegmental area dopamine neurons. J Neurosci 31:6710-6720. CrossRef Medline
36. Margolis EB, Coker AR, Driscoll JR, Lemaître AI, Fields HL (2010) Reliability in the identification of midbrain dopamine neurons. PLoS One 5:e15222. CrossRef Medline
37. Mark GP, Shabani S, Dobbs LK, Hansen ST (2011) Cholinergic modulation of mesolimbic dopamine function and reward. Physiol Behav 104:76-81. CrossRef Medline
38. Marks MJ, Stitzel JA, Collins AC (1985) Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther 235:619-628. Medline
39. Mascia P, Pistis M, Justinova Z, Panlilio LV, Luchicchi A, Lecca S, Scherma M, Fratta W, Fadda P, Barnes C, Redhi GH, Yasar S, Le Foll B, Tanda G, Piomelli D, Goldberg SR (2011) Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. Biol Psychiatry 69:633-641. CrossRef Medline
40. Melis M, Pillolla G, Bisogno T, Minassi A, Petrosino S, Perra S, Muntoni AL, Lutz B, Gessa GL, Marsicano G, Di Marzo V, PistisM (2006) Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiol Dis 24:15-27. CrossRef Medline
41. Melis M, Enrico P, Peana AT, Diana M (2007) Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system. Eur J Neurosci 26:2824-2833. CrossRef Medline
42. Melis M, Pillolla G, Luchicchi A, Muntoni AL, Yasar S, Goldberg SR, PistisM (2008) Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. J Neurosci 28:13985-13994. CrossRef Medline
43. Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M (2010) Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors. Biol Psychiatry 68:256-264. CrossRef Medline
44. Melis M, Carta G, Pistis M, Banni S (2013) Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems. CNS Neurol Disord Drug Targets 12:70-77. Medline
45. Mihalak KB, Carroll FI, Luetje CW (2006) Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70:801-805. CrossRef Medline
46. Mineur YS, Picciotto MR (2009) Biological basis for the co-morbidity between smoking and mood disorders. J Dual Diagn 5:122-130. CrossRef Medline
47. Mineur YS, Picciotto MR (2010) Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends Pharmacol Sci 31: 580-586. CrossRef Medline
48. Mineur YS, Einstein EB, Seymour PA, Coe JW, O'neill BT, Rollema H, Picciotto MR (2011) Alpha4beta2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties. Behav Pharmacol 22:291-299. CrossRef Medline
49. Newhouse P, Singh A, Potter A (2004) Nicotine and nicotinic receptor involvement in neuropsychiatric disorders. Curr Top Med Chem 4:267-282. CrossRef Medline
50. Panlilio LV, Justinova Z, Mascia P, Pistis M, Luchicchi A, Lecca S, Barnes C, Redhi GH, Adair J, Heishman SJ, Yasar S, Aliczki M, Haller J, Goldberg SR (2012) Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings. Neuropsychopharmacology 37:1838-1847. CrossRef Medline
51. Paradiso KG, Steinbach JH (2003) Nicotine is highly effective at producing desensitization of rat alpha4beta2 neuronal nicotinic receptors. J Physiol 553:857-871. CrossRef Medline
52. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates. San Diego: Academic.
53. Philip NS, Carpenter LL, Tyrka AR, Price LH (2010) Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology (Berl) 212:1-12. CrossRef Medline
54. Philip NS, Carpenter LL, Tyrka AR, Price LH (2012) The nicotinic acetylcholine receptor as a target for antidepressant drug development. Sci World J 2012:104105. CrossRef Medline
55. Picciotto MR, Zoli M, Rimondini R, Léna C, Marubio LM, Pich EM, Fuxe K, Changeux JP (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391:173-177. CrossRef Medline
56. Pichat P, Bergis OE, Terranova JP, Urani A, Duarte C, Santucci V, Gueudet C, Voltz C, Steinberg R, Stemmelin J, Oury-Donat F, Avenet P, Griebel G, Scatton B (2007) SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 32:17-34. CrossRef Medline
57. Piscitelli F, Carta G, Bisogno T, Murru E, Cordeddu L, Berge K, Tandy S, Cohn JS, Griinari M, Banni S, Di Marzo V (2011) Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice. Nutr Metab (Lond) 8:51. CrossRef Medline
58. Pistis M, Melis M (2010) From surface to nuclear receptors: the endocannabinoid family extends its assets. Curr Med Chem 17:1450-1467. CrossRef Medline
59. Plaza-Zabala A, Berrendero F, Suarez J, Bermudez-Silva FJ, Fernandez-Espejo E, Serrano A, Pavon FJ, Parsons LH, De Fonseca FR, Maldonado R, Robledo P (2010) Effects of the endogenous PPAR-alpha agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice. Synapse 64: 379-389. CrossRef Medline
60. Porsolt RD, Le Pichon M, JalfreM (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730-732. CrossRef Medline
61. Rodríguez de Fonseca F, Navarro M, Gómez R, Escuredo L, Nava F, Fu J, Murillo-Rodríguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C, Piomelli D (2001) An anorexic lipid mediator regulated by feeding. Nature 414:209-212. CrossRef Medline
62. Rolland B, Marche K, Cottencin O, Bordet R (2012) The PPARalpha agonist fenofibrate reduces prepulse inhibition disruption in a neurodevelopmental model of schizophrenia. Schizophr Res Treatment 2012:839853. CrossRef Medline
63. Salín-Pascual RJ, Rosas M, Jimenez-Genchi A, Rivera-Meza BL, Delgado-Parra V (1996) Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 57: 387-389. Medline
64. Schilström B, Rawal N, Mameli-Engvall M, Nomikos GG, Svensson TH (2003) Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes. Int J Neuropsychopharmacol 6:1-11. CrossRef Medline
65. Schomacher J, Farina D, Lindstroem R, Falla D (2012) Chronic traumainduced neck pain impairs the neural control of the deep semispinalis cervicis muscle. Clin Neurophysiol 123:1403-1408. CrossRef Medline
66. Schwartz RD, Kellar KJ (1983) Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220:214-216. CrossRef Medline
67. Séguéla P, Wadiche J, Dineley-Miller K, Dani JA, Patrick JW (1993) Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13:596-604. Medline
68. Shytle RD, Silver AA, Sheehan KH, Sheehan DV, Sanberg PR (2002) Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine. Depress Anxiety 16:89-92. CrossRef Medline
69. Stella N, Piomelli D (2001) Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur J Pharmacol 425:189-196. CrossRef Medline
70. Thomsen MS, Hansen HH, Timmerman DB, Mikkelsen JD (2010) Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology. Curr Pharm Des 16:323-343. CrossRef Medline
71. Ueda N, Puffenbarger RA, Yamamoto S, Deutsch DG (2000) The fatty acid amide hydrolase (FAAH). Chem Phys Lipids 108:107-121. CrossRef Medline
72. Umathe SN, Manna SS, Jain NS (2011) Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice. Behav Brain Res 223:125-134. CrossRef Medline
73. Wang DV, Tsien JZ (2011) Convergent processing of both positive and negative motivational signals by the VTA dopamine neuronal populations. PLoS One 6:e17047. CrossRef Medline
74. Wightman RM, Robinson DL (2002) Transient changes in mesolimbic dopamine and their association with "reward. " J Neurochem 82:721-735. CrossRef
75. Wooltorton JR, Pidoplichko VI, Broide RS, Dani JA (2003) Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci 23:3176-3185. Medline
76. Yang K, HuJ, Lucero L, Liu Q, Zheng C, Zhen X, Jin G, Lukas RJ, WuJ (2009) Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons. J Physiol 587:345-361. CrossRef Medline
77. Yu HL, Deng XQ, Li YJ, Li YC, Quan ZS, Sun XY (2011) N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice. Pharmacol Rep 63:834-839. Medline
78. Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, ValacchiM (2012) Discovery of a novel alpha-7 nicotinic acetylcholine receptor agonist series and characterization of the potent, selective, and orally efficacious agonist 5-(4-acetyl[1,4]diazepan-1-yl)pentanoic acid [5-(4-methoxyphenyl)-1H-pyrazol-3-yl] amide (SEN15924, WAY-361789). J Med Chem 55:4806-4823. CrossRef Medline
79. Zhang TA, Placzek AN, Dani JA (2010) In vitro identification and electrophysiological characterization of dopamine neurons in the ventral tegmental area. Neuropharmacology 59:431-436. CrossRef Medline